1. Home
  2. EBF vs LXRX Comparison

EBF vs LXRX Comparison

Compare EBF & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ennis Inc.

EBF

Ennis Inc.

HOLD

Current Price

$20.40

Market Cap

498.3M

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.31

Market Cap

465.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBF
LXRX
Founded
1909
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
498.3M
465.2M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
EBF
LXRX
Price
$20.40
$1.31
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$3.23
AVG Volume (30 Days)
176.9K
4.1M
Earning Date
12-22-2025
03-05-2026
Dividend Yield
4.87%
N/A
EPS Growth
5.01
N/A
EPS
1.66
N/A
Revenue
$388,740,000.00
$70,864,000.00
Revenue This Year
$0.11
$56.61
Revenue Next Year
$2.27
N/A
P/E Ratio
$12.37
N/A
Revenue Growth
N/A
1255.21
52 Week Low
$16.30
$0.28
52 Week High
$22.01
$1.83

Technical Indicators

Market Signals
Indicator
EBF
LXRX
Relative Strength Index (RSI) 67.01 49.20
Support Level $20.20 $1.17
Resistance Level $20.80 $1.39
Average True Range (ATR) 0.42 0.14
MACD 0.04 -0.01
Stochastic Oscillator 75.13 33.61

Price Performance

Historical Comparison
EBF
LXRX

About EBF Ennis Inc.

Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: